Jump to content
RemedySpot.com

YM155 a targeted agent to watch?

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 09

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

An Extension Study Administering YM155 to Subjects Previously Enrolled in

Another Protocol Administering YM155

http://clinicaltrials.gov/ct2/show/NCT00818480

This protocol is open to subjects previously enrolled in and who had

completed a Phase I or Phase II study administering YM155. Subjects who are

receiving benefit from treatment with YM155 are eligible after completing

the previous study.

YM155, a Novel Small-Molecule Survivin Suppressant

http://cancerres.aacrjournals.org/cgi/content/full/67/17/8014

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...